Home > Insider Trading > Filing (0001144204-15-051838)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1379006	Nanoviricides Inc.	NNVC	Services-Commercial Physical & Biological Research (8731)	760674577

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1580568	Milton Boniuk	C/O Nanoviricides, Inc. 1 Controls Drive Shelton CT 06484		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock, Par Value $0.001	Acquisiton	2015-08-13	800	$1.25	1,606,191	No	4	P	Direct
Common Stock, Par Value $0.001	Acquisiton	2015-08-14	8,594	$1.25	1,614,785	No	4	P	Direct
Common Stock, Par Value $0.001	Acquisiton	2015-08-17	5,244	$1.25	1,620,029	No	4	P	Direct
Common Stock, Par Value $0.001	Acquisiton	2015-08-18	2,547	$1.25	1,622,576	No	4	P	Direct
Common Stock, Par Value $0.001	Acquisiton	2015-08-19	300	$1.25	1,622,876	No	4	P	Direct
Common Stock, Par Value $0.001	Acquisiton	2015-08-20	2,662	$1.25	1,625,538	No	4	P	Direct
Common Stock, Par Value $0.001	Acquisiton	2015-08-21	29,853	$1.25	1,655,391	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct

Footnotes

Includes 1,083,963 shares of Common Stock and warrants to purchase an additional 571,428 shares of Common Stock held by the Reporting Person and his wife. Does not include: 942,859 shares of Common Stock, warrants to purchase an additional 285,714 shares of Common Stock or an indeterminate number of shares of Common Stock issuable upon conversion of debentures held by Boniuk Interests, Ltd.; 571,431 shares of Common Stock held by the Boniuk Charitable Foundation; or 50,000 shares of Common Stock, 952,381 shares of Common Stock issuable upon conversion of a 10% Coupon Series C Convertible Debenture, or 187,000 shares of Series A Preferred Stock held by Milton Boniuk IRA, convertible into 654,500 shares of common stock, which are not readily convertible. Dr. Boniuk holds voting and dispositive power over the Boniuk Charitable Foundation, Boniuk Interests Ltd. and the Milton Boniuk IRA.